GGHC
LEGN icon

Gilder Gagnon Howe & Co’s Legend Biotech LEGN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,768
Closed -$518K – 342
2020
Q3 		$518K Sell
16,768
-3,159
-16% -$106K ﹤0.01% 278
2020
Q2 		$848K Buy
+19,927
New +$779K 0.01% 239

Other funds holding LEGN

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Gilder Gagnon Howe & Co's LEGN Position: Q4 2020 in Review

Gilder Gagnon Howe & Co sold out of Legend Biotech (LEGN) in Q4 2020, closing a stake of 16,768 shares — an estimated $518K sold.

Gilder Gagnon Howe & Co first reported a position in LEGN in Q2 2020 and held it in 2 quarters. The position peaked at $848K in Q2 2020. 61 funds tracked by Wall St. Rank hold LEGN as of Q4 2020.

  • Gilder Gagnon Howe & Co reported no remaining Legend Biotech position as of Q4 2020 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 16,768 Legend Biotech shares in Q4 2020, an estimated $518K.
  • Gilder Gagnon Howe & Co first reported a position in Legend Biotech in Q2 2020 and held it in 2 quarters.
  • Gilder Gagnon Howe & Co's Legend Biotech position peaked at $848K in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2020.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2020, filed 16 Feb 2021.